Kaj Blennow (Former)
141 – 150 of 227
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Autocatalytic amplification of Alzheimer-associated Aβ42 peptide aggregation in human cerebrospinal fluid
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Predicting clinical decline and conversion to Alzheimer’s disease or dementia using novel Elecsys Aβ(1–42), pTau and tTau CSF immunoassays
(
- Contribution to journal › Article
-
Mark
Synaptic vesicle protein 2A as a potential biomarker in synaptopathies
(
- Contribution to journal › Scientific review
-
Mark
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia : An elusive quest
(
- Contribution to journal › Article
-
Mark
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
(
- Contribution to journal › Article
- 2018
-
Mark
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Apolipoprotein E genotypes and longevity across dementia disorders
(
- Contribution to journal › Article